CENTESSA PHARMACEUTICALS PLC's ticker is CNTA and the CUSIP is 152309100. A total of 48 filers reported holding CENTESSA PHARMACEUTICALS PLC in Q4 2021. The put-call ratio across all filers is - and the average weighting 4.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,577,532 | -44.3% | 2,114,519 | -64.1% | 0.01% | -44.4% |
| Q3 2022 | $11,798,787 | -29.4% | 5,889,912 | +71.8% | 0.01% | -25.0% |
| Q2 2022 | $16,722,000 | -66.8% | 3,428,520 | -39.0% | 0.01% | -50.0% |
| Q1 2022 | $50,406,000 | -20.2% | 5,617,819 | -2.2% | 0.02% | -7.7% |
| Q4 2021 | $63,137,000 | -30.9% | 5,743,397 | +2.4% | 0.03% | -35.0% |
| Q3 2021 | $91,362,000 | -23.9% | 5,607,302 | -1.3% | 0.04% | -21.6% |
| Q2 2021 | $120,122,000 | – | 5,680,933 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Index Venture Life Associates VI Ltd | 9,961,789 | $112,170,000 | 100.00% |
| Medicxi Ventures Management (Jersey) Ltd | 18,123,892 | $204,075,000 | 51.07% |
| Vida Ventures Advisors, LLC | 3,931,818 | $44,272,000 | 16.56% |
| OUP Management Co., LLC | 2,341,891 | $26,370,000 | 11.89% |
| Samsara BioCapital, LLC | 1,459,693 | $16,436,000 | 3.19% |
| VR Adviser, LLC | 1,127,272 | $12,693,000 | 1.74% |
| Affinity Asset Advisors, LLC | 419,144 | $4,720,000 | 1.71% |
| Cormorant Asset Management, LP | 2,489,894 | $28,036,000 | 1.67% |
| Kynam Capital Management, LP | 239,041 | $2,692,000 | 1.44% |
| GENERAL ATLANTIC, L.P. | 9,681,818 | $109,017,000 | 0.84% |